Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.76M 1.58M 1.45M 1.32M 2.49M 166M 2.57M 17.44M 6.95M 88.52M 6.62M 6.48M 279M | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -20.07M -18M -16.45M -15.02M -28.3M -1.89B -29.19M -198M -79.08M -1.01B -75.34M -73.73M -3.18B | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 57 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| -4.83% | +3.51% | +53.62% | +61.75% | 65.94B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 56.53B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 56.88B | |
| +5.09% | +9.89% | +22.45% | +107.48% | 46.49B | |
| +2.62% | +1.68% | +28.91% | +37.01% | 44.8B | |
| +8.24% | +0.51% | +213.26% | +792.66% | 41.59B | |
| -1.86% | +10.13% | +26.82% | +53.22% | 35.35B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 33.29B | |
| -2.18% | +7.06% | +36.06% | -4.95% | 24.92B | |
| Average | -0.39% | +3.25% | +56.16% | +144.47% | 45.09B | |
| Weighted average by Cap. | +0.21% | +3.40% | +53.12% | +142.96% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.56M 5.08M 4.64M 8.74M 583M 9.02M 61.26M 24.43M 311M 23.27M 22.77M 982M | 1.5M 1.35M 1.23M 1.12M 2.11M 141M 2.18M 14.82M 5.91M 75.24M 5.63M 5.51M 238M |
| Net income | -9.7M -8.7M -7.96M -7.26M -13.68M -912M -14.11M -95.89M -38.23M -487M -36.43M -35.65M -1.54B | -24.97M -22.4M -20.47M -18.69M -35.21M -2.35B -36.32M -247M -98.39M -1.25B -93.74M -91.73M -3.95B |
| Net Debt | -46.16M -41.4M -37.83M -34.54M -65.07M -4.34B -67.12M -456M -182M -2.32B -173M -170M -7.31B | -21.84M -19.59M -17.9M -16.34M -30.78M -2.05B -31.76M -216M -86.03M -1.1B -81.97M -80.21M -3.46B |
Employees
13
